Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20171
20181
20192
20214
20222
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed4
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
BeOne Medicines1
Curocell Inc.1
CytomX Therapeutics1
Genmab1
Incyte Corporation1
Janssen Research & Development, LLC1
Kartos Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Non-Hodgkin6
Lymphoma, Follicular4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma3
Lymphoma, B-Cell3
Burkitt Lymphoma2
Leukemia, Myeloid, Acute2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Mantle-Cell2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.